{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-001534","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2026-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.170141+00:00","generated_at":"2026-05-16T01:26:31.577064+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"confidence":"high","headline":"KALA Bio director David Lazar resigns from board effective February 16, 2026","bullets":["David Lazar resigned as a member of the Board of Directors of KALA Bio on February 16, 2026.","Resignation was effective immediately and not due to any disagreement with the company.","No replacement for Lazar's board seat has been announced in this filing.","The company filed the 8-K on February 20, 2026, reflecting the departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-001534","json":"https://secwatch.observer/filing/0001829126-26-001534.json","markdown":"https://secwatch.observer/filing/0001829126-26-001534.md","text":"https://secwatch.observer/filing/0001829126-26-001534.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626001534/0001829126-26-001534-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626001534/kalabio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:26:31.577064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}